Nauck, M. A. Et Al. 2018. Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial. DIABETES CARE , vol.41, no.8 , 1663-1671.

Nauck, M. A., Jensen, T. J., Rosenkilde, C., Calanna, S., & Buse, J. B., (2018). Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial. DIABETES CARE , vol.41, no.8, 1663-1671.

Nauck, Michael Et Al. "Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial," DIABETES CARE , vol.41, no.8, 1663-1671, 2018

Nauck, Michael A. Et Al. "Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial." DIABETES CARE , vol.41, no.8, pp.1663-1671, 2018

Nauck, M. A. Et Al. (2018) . "Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial." DIABETES CARE , vol.41, no.8, pp.1663-1671.

@article{article, author={Michael A. Nauck Et Al. }, title={Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial}, journal={DIABETES CARE}, year=2018, pages={1663-1671} }